Clinical Trials Logo

Clinical Trial Summary

Double-blind, randomized, placebo-controlled, clinical trial. Patients with diabetic neuropathy will be randomly assigned to treatment with either TENS or TENS sham three times a week during 90 days. Clinical determinations are: pain, levesls of TNF-alpha, IL-6 and RPC-us


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04253860
Study type Interventional
Source Centro Universitario de Tonalá
Contact
Status Terminated
Phase Phase 3
Start date February 1, 2019
Completion date July 30, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05558878 - Effect of Ambroxol in Diabetic Peripheral Neuropathy N/A
Completed NCT03676595 - Video Game Balance Training for Patients With Diabetic Neuropathy N/A
Completed NCT03440203 - Prevalence of Peripheral Neuropathy and Its Impact on Activities of Daily Living in Patients With Type 2 Diabetes
Completed NCT03455543 - Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy N/A
Recruiting NCT03725917 - Patients With Diabetic Neuropathy Who Receive Physiotherapy Treatment Will Have a Decrease in Diabetic Foot Ulcers N/A
Enrolling by invitation NCT03907189 - Ambulation as a Factor on Oscillating Thermometry
Completed NCT03888872 - Effect of High Tone Power Therapy on Neurophysiological Measures and Function Outcome in Patients With Diabetic Neuropathy N/A
Withdrawn NCT03354806 - Peripheral Analgesia in Painful Diabetic Neuropathy N/A
Enrolling by invitation NCT05921097 - Comparison of Histamine and Local Heating for Evoking the Axon-reflex Flare Response in Diabetes
Active, not recruiting NCT06463015 - Posterior Tibial Nerve PRF for Diabetic Neuropathic Pain N/A
Completed NCT05299918 - Diabetic Neuropathy Rapid Screening Test in Turkish Patients With Type 2 Diabetes: Sudoscan
Not yet recruiting NCT06201611 - Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy. Phase 2/Phase 3
Suspended NCT03685253 - Nicotinamide Riboside for Diabetic Neuropathy Phase 1/Phase 2
Completed NCT05977465 - Empagliflozin in Treatment of Peripheral Diabetic Neuropathy Phase 1/Phase 2
Completed NCT03847779 - Microcirculatory Vasomotor Changes in Type 2 Diabetes With Peripheral Neuropathy N/A
Recruiting NCT05642143 - Deep Phenotyping of Bone Disease in Type 2 Diabetes and Relations to Diabetic Neuropathy
Completed NCT03988413 - Study on Safety, Absorption and Metabolism of SYHA1402 Tablets in Healthy People Phase 1
Not yet recruiting NCT05461274 - Determining Patterns In Trial Experiences of Diabetic Neuropathy Patients
Recruiting NCT04841720 - A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride Tablets Phase 1